3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
4
Neoplasm Metastasis
3
Keratosis, Actinic
3
Warts
2
Uterine Cervical Dysplasia
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pleural Neoplasms
1
Pancreatic Neoplasms
1
Pain
1
Neoplasms
1
Multiple Myeloma
1
Mucositis
1
Mesothelioma
1
Gastrointestinal Neoplasms
1
Gastro-enteropancreatic neuroendocrine tumor
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
CIPN - Chemotherapy-Induced Peripheral Neuropathy
1
Breast Neoplasms
1
Appendiceal Neoplasms
1
Anus Neoplasms
1
Adenoma, Islet Cell
1
Interventions
X-Rays
5
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
Vemurafenib
2
LY3023414
2
sonidegib
1
sodium thiosulfate
1
ensartinib
1
cixutumumab
1
cabozantinib
1
Restraint, Physical
1
Pharmacogenomic Variants
1
MLN 8237
1
Cyproheptadine
1
Arsenic Trioxide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hepatoblastoma
×
Cryotherapy
×
Clear all
No trials found.